亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應CAS號:137-08-6D-泛酸鈣
廠家供應CAS號:137-08-6D-泛酸鈣
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 137-08-6
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:00
 
詳細信息
D-泛酸鈣

中文別名:維生素B5;泛酸鈣;
CAS號:137-08-6
分子量:476.54
分子式:C9H17NO5.1/2Ca
D-泛酸鈣
別名 本多生酸鈣
英文名 D-Pantothenic acid calcium salt
CAS# 137-08-6
分子式 C18H12CaN2O10
分子量 476.54
白色針狀結晶或粉末
D-泛酸鈣

中文別名:維生素B5;泛酸鈣;
CAS號:137-08-6
分子量:476.54
分子式:C9H17NO5.1/2Ca
D-泛酸鈣
別名 本多生酸鈣
英文名 D-Pantothenic acid calcium salt
CAS# 137-08-6
分子式 C18H12CaN2O10
分子量 476.54
白色針狀結晶或粉末
©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:28441  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |